Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoantigen”

172 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 172 results

Testing effectiveness (Phase 2)Study completedNCT06614140
What this trial is testing

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Who this might be right for
CancerSolid Tumor, Adult
Seqker Biosciences, Inc. 8
Testing effectiveness (Phase 2)Looking for participantsNCT07495215
What this trial is testing

A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection

Who this might be right for
Hepatocellular Carcinoma (HCC)
Yinghua Xu 20
Not applicableNo Longer AvailableNCT03914872
What this trial is testing

Expanded Access Neoantigen Vaccine in Solid Tumors

Who this might be right for
Solid Tumor, Adult
Washington University School of Medicine
Not applicableUnknownNCT05192460
What this trial is testing

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer

Who this might be right for
Gastric CancerEsophageal CancerLiver Cancer
jianming xu 30
Early research (Phase 1)Study completedNCT02959905
What this trial is testing

Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

Who this might be right for
Solid Cancer
BGI, China 11
Very early researchUnknownNCT06431529
What this trial is testing

Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors

Who this might be right for
Tumor, Solid
JIANG LONGWEI 6
Not applicableUnknownNCT06095934
What this trial is testing

Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment

Who this might be right for
NSCLCEGFR Gene Mutation
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 20
Early research (Phase 1)Study completedNCT03289962
What this trial is testing

Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
MelanomaNon-Small Cell Lung CancerBladder Cancer+5 more
Genentech, Inc. 273
Not applicableUnknownNCT05359354
What this trial is testing

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors

Who this might be right for
Solid Tumor
YueJuan Cheng 36
Not applicableUnknownNCT04145232
What this trial is testing

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Who this might be right for
Non Small Cell Lung CancerNeoepitopesNeoantigens+3 more
Ardigen 30
Testing effectiveness (Phase 2)Looking for participantsNCT06956716
What this trial is testing

Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Advanced Intrahepatic Cholangiocarcinoma
Zhejiang University 30
Very early researchEnrolling By InvitationNCT07316361
What this trial is testing

GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial Carcinoma Stage III
Biogenea Pharmaceuticals Ltd. 40
Early research (Phase 1)UnknownNCT05235607
What this trial is testing

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Who this might be right for
CarcinomaMelanomaBladder Cancer+1 more
Sichuan University 60
Very early researchNot Yet RecruitingNCT06156267
What this trial is testing

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Who this might be right for
Pancreatic Cancer
Fudan University 30
Early research (Phase 1)UnknownNCT02956551
What this trial is testing

Personalized DC Vaccine for Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sichuan University 20
Early research (Phase 1)Active Not RecruitingNCT02950766
What this trial is testing

NeoVax Plus Ipilimumab in Renal Cell Carcinoma

Who this might be right for
Kidney Cancer
Patrick Ott, MD, PhD 19
Testing effectiveness (Phase 2)Ended earlyNCT04785365
What this trial is testing

Long-Term Follow-Up Study of Patients Receiving ATL001

Who this might be right for
MelanomaAdvanced Non Small Cell Lung Cancer
Achilles Therapeutics UK Limited 1
Early research (Phase 1)Study completedNCT05111353
What this trial is testing

Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery

Who this might be right for
Pancreas CancerPancreatic CancerCancer of the Pancreas
Washington University School of Medicine 33
Not applicableStudy completedNCT05158621
What this trial is testing

A Screening Study Targeting Tumor-specific Antigens

Who this might be right for
Metastatic Colorectal CancerStage II/III Colon Cancer
Gritstone bio, Inc. 22
Early research (Phase 1)Study completedNCT07504484
What this trial is testing

Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer

Who this might be right for
CRC (Colorectal Cancer)Non Small Lung Cancer
Ying Yuan, MD 6
Load More Results